Search

everythinglearnresearchcommunity

for

Search:↓

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

Patched1 helps prevent tumors by controlling cell growth.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Runx1 and CDK inhibitors help keep hair follicle stem cells inactive, affecting their future roles.

CDK4 levels affect the number of hair follicle stem cells in mice.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Blocking mTORC1 reduces skin tumor growth in mice.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

Akt2 protein is essential for normal cell division in early mouse embryos.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

CXCR2 in skin cells promotes tumor growth.

Normal human melanocytes can avoid cell death through multiple pathways.

The conclusion is that the IL-6/STAT3 activation affects p63 expression in healing wounds, which may help in hair follicle regeneration.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

p63 controls Satb1 to help skin develop properly.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Blocking YAP/TAZ could be a new way to treat skin cancer.

The study found that p63 needs signals from morphogens to help skin cells differentiate properly.